NCCN Guidelines Implementation in the Multidisciplinary Merkel Cell Carcinoma Program at the University of Michigan

View More View Less
  • a From the Departments of Dermatology, Surgery, Otolaryngology, Radiation Oncology, Internal Medicine, and Pathology, University of Michigan Health System, Ann Arbor, Michigan.
Restricted access

Merkel cell carcinoma (MCC) is a rare malignancy of the skin, and prospective randomized clinical studies on management and treatment are very limited. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for MCC provide up-to-date, best evidence-based, and consensus-driven management pathways with the purpose of providing best care and outcomes. Multidisciplinary management with consensus treatment recommendations to individualize patient care within the framework of these guidelines is optimal. The University of Michigan multidisciplinary MCC program uses NCCN Guidelines in the management and treatment of its patients. This article discusses 4 patient presentations to highlight the implementation of the NCCN Guidelines for MCC at the University of Michigan.

Correspondence: Jennifer L. Schwartz, MD, University of Michigan Health System, 1910 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0314. E-mail: jennschw@med.umich.edu
  • 1.

    Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005;89:14.

  • 2.

    Heath M, Jaimes N, Lemos B. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008;58:375381.

    • Search Google Scholar
    • Export Citation
  • 3.

    Medina-Franco H, Urist MM, Fiveash J. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2001;8:204208.

    • Search Google Scholar
    • Export Citation
  • 4.

    Allen PJ, Bowne WB, Jaques DP. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:23002309.

    • Search Google Scholar
    • Export Citation
  • 5.

    Schwartz JL, Bichakjian CK, Lowe L. Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort. Dermatol Surg 2013;39:10091016.

    • Search Google Scholar
    • Export Citation
  • 6.

    Engels EA, Frisch M, Goedert JJ. Merkel cell carcinoma and HIV infection. Lancet 2002;359:497498.

  • 7.

    7. Tadmor T, Aviv A, Polliack A. Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol 2011;22:250256.

    • Search Google Scholar
    • Export Citation
  • 8.

    Agelli M, Clegg LX, Becker JC, Rollison DE. The etiology and epidemiology of merkel cell carcinoma. Curr Probl Cancer 2010;34:1437.

  • 9.

    Lemos BD, Storer BE, Iyer JG. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010;63:751761.

    • Search Google Scholar
    • Export Citation
  • 10.

    Gillenwater AM, Hessel AC, Morrison WH. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001;127:149154.

    • Search Google Scholar
    • Export Citation
  • 11.

    Eng TY, Naguib M, Fuller CD. Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases. Am J Clin Oncol 2004;27:576583.

  • 12.

    Messina JL, Reintgen DS, Cruse CW. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997;4:389395.

    • Search Google Scholar
    • Export Citation
  • 13.

    Mehrany K, Otley CC, Weenig RH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002;28:113117; discussion 117.

    • Search Google Scholar
    • Export Citation
  • 14.

    Gupta SG, Wang LC, Penas PF. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006;142:685690.

    • Search Google Scholar
    • Export Citation
  • 15.

    Edge SB, Byrd DR, Carducci M, eds. AJCC Cancer Staging Manual, 7th ed. New York, NY: Springer; 2009.

  • 16.

    Llombart B, Monteagudo C, Lopez-Guerrero JA. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology 2005;46:622634.

    • Search Google Scholar
    • Export Citation
  • 17.

    Sandel HD 4th, Day T, Richardson MS. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope 2006;116:791795.

    • Search Google Scholar
    • Export Citation
  • 18.

    Bichakjian CK, Lowe L, Lao CD. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007;110:112.

    • Search Google Scholar
    • Export Citation
  • 19.

    Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008;113:25492558.

  • 20.

    Fields RC, Busam KJ, Chou JF. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 2011;18:25292537.

    • Search Google Scholar
    • Export Citation
  • 21.

    Fields RC, Busam KJ, Chou JF. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg 2011;254:465473.

  • 22.

    Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:10961100.

  • 23.

    Aiello Bowles EJ, Tuzzio L, Wiese CJ. Understanding high-quality cancer care: a summary of expert perspectives. Cancer 2008;112:934942.

  • 24.

    Bichakjian CK, Olencki T, Alam M. NCCN Clinical Practice Guidelines in Oncology: Merkel Cell Carcinoma. Version 1, 2014. Available at: NCCN.org. Accessed February 10, 2014.

    • Search Google Scholar
    • Export Citation
  • 25.

    Sarnaik AA, Lien MH, Nghiem P, Bichakjian CK. Clinical recognition, diagnosis, and staging of merkel cell carcinoma, and the role of the multidisciplinary management team. Curr Probl Cancer 2010;34:3846.

    • Search Google Scholar
    • Export Citation
  • 26.

    Schneider S, Thurnher D, Erovic BM. Merkel cell carcinoma: interdisciplinary management of a rare disease. J Skin Cancer 2013;2013:189342.

  • 27.

    Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 1994;70:363370.

  • 28.

    Stephens MR, Lewis WG, Brewster AE. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus 2006;19:164171.

    • Search Google Scholar
    • Export Citation
  • 29.

    Johnson TM, Chang A, Redman B. Management of melanoma with a multidisciplinary melanoma clinic model. J Am Acad Dermatol 2000;42:820826.

  • 30.

    Fader DJ, Wise CG, Normolle DP, Johnson TM. The multidisciplinary melanoma clinic: a cost outcomes analysis of specialty care. J Am Acad Dermatol 1998;38:742751.

    • Search Google Scholar
    • Export Citation
  • 31.

    Bichakjian CK, Coit DG, Wong SL. Radiation versus resection for Merkel cell carcinoma. Cancer 2010;116:16201622.

  • 32.

    Erman AB, Collar RM, Griffith KA. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer 2012;118:10401047.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 770 523 49
PDF Downloads 38 26 1
EPUB Downloads 0 0 0